CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 1,119 enrolled
Drug / intervention
Vonoprazandrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03214094
NCT03214094N/ACompleted
CompareCT.gov

Special Drug Use Surveillance of Takecab Tablets for "Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Low-dose Aspirin: Long-term Use"

Takeda·observational·Posted Jul 11, 2017·Updated Mar 11, 2020

In Brief

An observational study evaluating Vonoprazan for Gastric or Duodenal Ulcers. Completed, enrolled 1,119 participants across 1 site.

Detailed Summary

The purpose of this survey is to investigate the safety and effectiveness of long-term administration of vonoprazan tablets for up to 12 months in the routine clinical setting in patients receiving low-dose aspirin.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsGastric or Duodenal Ulcers
CountriesJapan
Collaborators--

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedJul 11, 2017
Enrollment StartSep 1, 2016
Primary CompletionFeb 28, 2019
TodayJul 2, 2026
Enrollment to primary: 2.5 yearsPosted 9.0 years ago

Interventions

Vonoprazandrug

Vonoprazan tablets